Loading...
Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies
BACKGROUND: Oncolytic viral tumor therapy is an emerging field in the fight against cancer with rising numbers of clinical trials and the first clinically approved product (Adenovirus for the treatment of Head and Neck Cancer in China) in this field. Yet, until recently no general (bio)marker or rep...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3207905/ https://ncbi.nlm.nih.gov/pubmed/21989091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-9-172 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|